Mark A Goldsmith Revolution Medicines, Inc. (RVMD) insider trading activity

Mark A Goldsmith is of Revolution Medicines, Inc.. Currently has a direct ownership of 300,170 shares of RVMD, which is worth approximately $17.3 Million. The most recent transaction as insider was on Nov 04, 2024, when has been sold 50,900 shares (Common Stock) at a price of $55.56 per share, resulting in proceeds of $2,828,004. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 300K

3.76% 3M change

21.9% 12M change

Total Value Held $17.3 Million

MARK A GOLDSMITH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 04 2024	SELL Open market or private sale	$2,828,004 $55.56 p/Share	50,900 Reduced 14.5%	300,170 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$200,375 $2.29 p/Share	87,500 Added 20.62%	336,770 Common Stock
Nov 01 2024	SELL Open market or private sale	$500,682 $55.02 p/Share	9,100 Reduced 2.94%	300,170 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$37,219 $4.09 p/Share	9,100 Added 2.86%	309,270 Common Stock
Oct 11 2024	SELL Open market or private sale	$1,510,800 $50.36 p/Share	30,000 Reduced 9.09%	300,170 Common Stock
Oct 11 2024	BUY Exercise of conversion of derivative security	$122,700 $4.09 p/Share	30,000 Added 8.33%	330,170 Common Stock
Oct 01 2024	SELL Open market or private sale	$451,300 $45.13 p/Share	10,000 Reduced 3.22%	300,170 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$40,900 $4.09 p/Share	10,000 Added 3.12%	310,170 Common Stock
Sep 16 2024	SELL Open market or private sale	$517,685 $44.19 p/Share	11,715 Reduced 3.76%	300,170 Common Stock
Aug 01 2024	SELL Open market or private sale	$460,400 $46.04 p/Share	10,000 Reduced 3.11%	311,885 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$40,900 $4.09 p/Share	10,000 Added 3.01%	321,885 Common Stock
Jul 12 2024	SELL Open market or private sale	$1,126,250 $45.05 p/Share	25,000 Reduced 7.42%	311,885 Common Stock
Jul 12 2024	BUY Exercise of conversion of derivative security	$102,250 $4.09 p/Share	25,000 Added 6.91%	336,885 Common Stock
Jun 17 2024	SELL Open market or private sale	$446,810 $37.39 p/Share	11,950 Reduced 3.69%	311,885 Common Stock
Jun 03 2024	SELL Open market or private sale	$300,000 $40.0 p/Share	7,500 Reduced 2.27%	322,322 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$30,675 $4.09 p/Share	7,500 Added 2.22%	329,822 Common Stock
Apr 10 2024	SELL Open market or private sale	$266,100 $35.48 p/Share	7,500 Reduced 1.63%	452,879 Common Stock
Mar 18 2024	SELL Open market or private sale	$182,785 $31.58 p/Share	5,788 Reduced 1.24%	460,379 Common Stock
Mar 01 2024	SELL Grant, award, or other acquisition	-	90,000 Reduced 16.18%	466,167 Common Stock
Dec 18 2023	SELL Open market or private sale	$211,473 $25.9 p/Share	8,165 Reduced 2.12%	376,167 Common Stock
Oct 24 2023	BUY Exercise of conversion of derivative security	$17,150 $0.49 p/Share	35,000 Added 8.35%	384,332 Common Stock
Sep 18 2023	SELL Open market or private sale	$252,170 $31.31 p/Share	8,054 Reduced 2.25%	349,332 Common Stock
Sep 01 2023	SELL Open market or private sale	$1,051,500 $35.05 p/Share	30,000 Reduced 7.74%	357,386 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$24,900 $0.83 p/Share	30,000 Added 7.19%	387,386 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	104,000 Added 22.61%	355,872 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

MAG

Mark A Goldsmith

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account